https://www.yiliao.com/index.php?action=history&feed=atom&title=Bim
Bim - 版本历史
2026-04-18T23:20:49Z
本wiki的该页面的版本历史
MediaWiki 1.35.1
https://www.yiliao.com/index.php?title=Bim&diff=316042&oldid=prev
77921020：建立内容为“<div style="padding: 0 4%; line-height: 1.8; color: #1e293b; font-family: 'Helvetica Neue', Helvetica, 'PingFang SC', Arial, sans-serif; background-color: #ffffff…”的新页面
2026-01-28T11:46:08Z
<p>建立内容为“<div style="padding: 0 4%; line-height: 1.8; color: #1e293b; font-family: 'Helvetica Neue', Helvetica, 'PingFang SC', Arial, sans-serif; background-color: #ffffff…”的新页面</p>
<p><b>新页面</b></p><div><div style="padding: 0 4%; line-height: 1.8; color: #1e293b; font-family: 'Helvetica Neue', Helvetica, 'PingFang SC', Arial, sans-serif; background-color: #ffffff; max-width: 1200px; margin: auto;"><br />
<br />
<div style="margin-bottom: 30px; border-bottom: 1.2px solid #e2e8f0; padding-bottom: 25px;"><br />
<p style="font-size: 1.1em; margin: 10px 0; color: #334155; text-align: justify;"><br />
<strong>Bim</strong>（Bcl-2 Interacting Mediator of cell death），由基因 <strong>[[BCL2L11]]</strong> 编码，是 Bcl-2 家族中杀伤力最强的 <strong>BH3-only</strong> 促凋亡蛋白之一。Bim 被称为细胞凋亡的“广谱处刑者”，它不仅能结合并中和所有主要的抗凋亡蛋白（Bcl-2, Bcl-xL, Mcl-1），还能<strong>直接结合并激活</strong>效应蛋白 <strong>[[Bax]]</strong> 和 <strong>[[Bak]]</strong>，直接触发线粒体外膜通透性（MOMP）。Bim 在<strong>[[失巢凋亡]]</strong>（Anoikis）、T 细胞阴性选择以及对靶向药物（如 EGFR 抑制剂）的响应中起决定性作用。其活性受到转录（FOXO3a）、可变剪接及磷酸化（ERK 通路）的多重严密调控。<br />
</p><br />
</div><br />
<br />
<div class="medical-infobox mw-collapsible mw-collapsed" style="width: 100%; max-width: 320px; margin: 0 auto 35px auto; border: 1.2px solid #bae6fd; border-radius: 12px; background-color: #ffffff; box-shadow: 0 8px 20px rgba(0,0,0,0.05); overflow: hidden;"><br />
<br />
<div style="padding: 15px; color: #1e40af; background: linear-gradient(135deg, #e0f2fe 0%, #bae6fd 100%); text-align: center; cursor: pointer;"><br />
<div style="font-size: 1.2em; font-weight: bold; letter-spacing: 1.2px;">Bim</div><br />
<div style="font-size: 0.7em; opacity: 0.85; margin-top: 4px; white-space: nowrap;">BCL2L11 / The Executioner (点击展开)</div><br />
</div><br />
<br />
<div class="mw-collapsible-content"><br />
<div style="padding: 25px; text-align: center; background-color: #f8fafc;"><br />
[Image:Bim_isoforms_structure_EL_L_S]<br />
<div style="font-size: 0.8em; color: #64748b; margin-top: 12px; font-weight: 600;">结构：BH3 域恒定，DLC1 结合域可变</div><br />
</div><br />
<br />
<table style="width: 100%; border-spacing: 0; border-collapse: collapse; font-size: 0.85em;"><br />
<tr><br />
<th colspan="2" style="padding: 8px 12px; background-color: #e0f2fe; color: #1e40af; text-align: left; font-size: 0.9em; border-top: 1px solid #bae6fd;">基础遗传学参数</th><br />
</tr><br />
<tr><br />
<th style="text-align: left; padding: 6px 12px; background-color: #f8fafc; color: #475569; border-bottom: 1px solid #e2e8f0; width: 40%;">基因符号</th><br />
<td style="padding: 6px 12px; border-bottom: 1px solid #e2e8f0; color: #0f172a;">BCL2L11</td><br />
</tr><br />
<tr><br />
<th style="text-align: left; padding: 6px 12px; background-color: #f8fafc; color: #475569; border-bottom: 1px solid #e2e8f0;">染色体定位</th><br />
<td style="padding: 6px 12px; border-bottom: 1px solid #e2e8f0; color: #1e40af;">2q13</td><br />
</tr><br />
<tr><br />
<th style="text-align: left; padding: 6px 12px; background-color: #f8fafc; color: #475569; border-bottom: 1px solid #e2e8f0;">UniProt ID</th><br />
<td style="padding: 6px 12px; border-bottom: 1px solid #e2e8f0; color: #0f172a;">O43521</td><br />
</tr><br />
<tr><br />
<th style="text-align: left; padding: 6px 12px; background-color: #f8fafc; color: #475569; border-bottom: 1px solid #e2e8f0;">功能分类</th><br />
<td style="padding: 6px 12px; border-bottom: 1px solid #e2e8f0; color: #b91c1c;">BH3-only (Activator Type)</td><br />
</tr><br />
<br />
<tr><br />
<th colspan="2" style="padding: 8px 12px; background-color: #e0f2fe; color: #1e40af; text-align: left; font-size: 0.9em; border-top: 1px solid #bae6fd;">主要异构体 (Splicing)</th><br />
</tr><br />
<tr><br />
<th style="text-align: left; padding: 6px 12px; background-color: #f8fafc; color: #475569; border-bottom: 1px solid #e2e8f0;">BimEL (Extra Long)</th><br />
<td style="padding: 6px 12px; border-bottom: 1px solid #e2e8f0; color: #0f172a;">198 aa (含量最高，受 ERK 调控)</td><br />
</tr><br />
<tr><br />
<th style="text-align: left; padding: 6px 12px; background-color: #f8fafc; color: #475569; border-bottom: 1px solid #e2e8f0;">BimL (Long)</th><br />
<td style="padding: 6px 12px; border-bottom: 1px solid #e2e8f0; color: #0f172a;">140 aa (结合细胞骨架)</td><br />
</tr><br />
<tr><br />
<th style="text-align: left; padding: 6px 12px; background-color: #f8fafc; color: #475569; border-bottom: 1px solid #e2e8f0;">BimS (Short)</th><br />
<td style="padding: 6px 12px; border-bottom: 1px solid #e2e8f0; color: #b91c1c;">110 aa (<strong>最强毒性</strong>，直接致死)</td><br />
</tr><br />
<br />
<tr><br />
<th colspan="2" style="padding: 8px 12px; background-color: #e0f2fe; color: #1e40af; text-align: left; font-size: 0.9em; border-top: 1px solid #bae6fd;">调控与互作</th><br />
</tr><br />
<tr><br />
<th style="text-align: left; padding: 6px 12px; background-color: #f8fafc; color: #475569; border-bottom: 1px solid #e2e8f0;">转录因子</th><br />
<td style="padding: 6px 12px; border-bottom: 1px solid #e2e8f0; color: #16a34a;"><strong>[[FOXO3a]]</strong>, E2F1, SMAD3</td><br />
</tr><br />
<tr><br />
<th style="text-align: left; padding: 6px 12px; background-color: #f8fafc; color: #475569; border-bottom: 1px solid #e2e8f0;">负调控激酶</th><br />
<td style="padding: 6px 12px; border-bottom: 1px solid #e2e8f0; color: #16a34a;"><strong>[[ERK1/2]]</strong> (磷酸化Ser69 -> 降解)</td><br />
</tr><br />
<tr><br />
<th style="text-align: left; padding: 6px 12px; background-color: #f8fafc; color: #475569; border-bottom: 1px solid #e2e8f0;">E3 连接酶</th><br />
<td style="padding: 6px 12px; border-bottom: 1px solid #e2e8f0; color: #0f172a;">Beta-TrCP (识别磷酸化Bim)</td><br />
</tr><br />
<tr><br />
<th style="text-align: left; padding: 6px 12px; background-color: #f8fafc; color: #475569; border-bottom: 1px solid #e2e8f0;">骨架结合</th><br />
<td style="padding: 6px 12px; border-bottom: 1px solid #e2e8f0; color: #0f172a;">[[DLC1]] (动力蛋白轻链)</td><br />
</tr><br />
<br />
<tr><br />
<th colspan="2" style="padding: 8px 12px; background-color: #e0f2fe; color: #1e40af; text-align: left; font-size: 0.9em; border-top: 1px solid #bae6fd;">临床相关</th><br />
</tr><br />
<tr><br />
<th style="text-align: left; padding: 6px 12px; background-color: #f8fafc; color: #475569; border-bottom: 1px solid #e2e8f0;">关键现象</th><br />
<td style="padding: 6px 12px; border-bottom: 1px solid #e2e8f0; color: #0f172a;"><strong>[[失巢凋亡]]</strong> (Anoikis)</td><br />
</tr><br />
<tr><br />
<th style="text-align: left; padding: 6px 12px; background-color: #f8fafc; color: #475569; border-bottom: 1px solid #e2e8f0;">药物靶点</th><br />
<td style="padding: 6px 12px; border-bottom: 1px solid #e2e8f0; color: #16a34a;">EGFR-TKI ([[奥希替尼]]) 的效应子</td><br />
</tr><br />
<tr><br />
<th style="text-align: left; padding: 6px 12px; background-color: #f8fafc; color: #475569;">遗传变异</th><br />
<td style="padding: 6px 12px; color: #b91c1c;">Bim缺失多态性 (东亚人群, 耐药)</td><br />
</tr><br />
</table><br />
</div><br />
</div><br />
<br />
<h2 style="background: #f1f5f9; color: #0f172a; padding: 10px 18px; border-radius: 0 6px 6px 0; font-size: 1.25em; margin-top: 40px; border-left: 6px solid #0f172a; font-weight: bold;">分子机制：被囚禁的杀手</h2><br />
<br />
<p style="margin: 15px 0; text-align: justify;"><br />
Bim 的活性调控极其精妙，主要通过剪接和细胞定位来实现：<br />
</p><br />
<br />
[Image:Bim_sequestration_cytoskeleton_release_mechanism]<br />
<br />
<ul style="padding-left: 25px; color: #334155;"><br />
<li style="margin-bottom: 12px;"><strong>BimEL 和 BimL (被囚禁)：</strong> <br />
<br>这两种较长的异构体含有一个 <strong>DLC1 结合域</strong>。在健康细胞中，它们结合动力蛋白轻链（DLC1/LC8），被“锁”在微管细胞骨架上，无法到达线粒体。当细胞受到应激（如紫杉醇破坏微管）时，它们被释放并转移至线粒体膜。</li><br />
<li style="margin-bottom: 12px;"><strong>BimS (自由杀手)：</strong> <br />
<br>最短的异构体 BimS <strong>缺失</strong> DLC1 结合域。因此，它不受细胞骨架束缚，一经合成便直接定位至线粒体，具有极强的细胞毒性。通常细胞通过严密的转录控制使其维持在极低水平。</li><br />
<li style="margin-bottom: 12px;"><strong>直接激活 (Direct Activation)：</strong> <br />
<br>Bim 是为数不多的“激活型”BH3-only 蛋白（另一个是 [[Bid]]/tBid）。它不仅能像 [[Bad]] 或 [[Noxa]] 那样通过结合抗凋亡蛋白来释放其他促凋亡因子，还能<strong>直接结合 Bax 和 Bak</strong>，触发其构象改变和寡聚化，直接打孔线粒体。</li><br />
</ul><br />
<br />
<h2 style="background: #f1f5f9; color: #0f172a; padding: 10px 18px; border-radius: 0 6px 6px 0; font-size: 1.25em; margin-top: 40px; border-left: 6px solid #0f172a; font-weight: bold;">磷酸化开关：生存与死亡的抉择</h2><br />
<br />
<div style="background-color: #f0f9ff; border-left: 5px solid #1e40af; padding: 15px 20px; margin: 20px 0; border-radius: 4px;"><br />
<h3 style="margin-top: 0; color: #1e40af; font-size: 1.1em;">ERK 通路的抑制作用</h3><br />
<p style="margin-bottom: 0; text-align: justify; font-size: 0.95em; color: #334155;"><br />
生长因子信号（[[MAPK]]/ERK 通路）是细胞存活的关键。激活的 <strong>ERK1/2</strong> 会磷酸化 BimEL 的 <strong>Ser69</strong> 位点。这一磷酸化标记使得 BimEL 被 E3 连接酶（[[Beta-TrCP]]）识别并<strong>泛素化降解</strong>。<br />
<br><strong>临床推论：</strong> 使用 [[EGFR]] 抑制剂或 [[BRAF]] 抑制剂阻断 MAPK 通路，会导致 Bim 去磷酸化并稳定积累，从而诱导肿瘤细胞凋亡。<br />
</p><br />
</div><br />
<br />
<h2 style="background: #f1f5f9; color: #0f172a; padding: 10px 18px; border-radius: 0 6px 6px 0; font-size: 1.25em; margin-top: 40px; border-left: 6px solid #0f172a; font-weight: bold;">临床转化：靶向治疗的晴雨表</h2><br />
<div style="overflow-x: auto; margin: 30px auto; max-width: 95%;"><br />
<table style="width: 100%; border-collapse: collapse; border: 1.2px solid #cbd5e1; font-size: 0.9em; text-align: left;"><br />
<tr style="background-color: #f8fafc; border-bottom: 2px solid #0f172a;"><br />
<th style="padding: 12px; border: 1px solid #cbd5e1; color: #0f172a; width: 25%;">疾病/药物</th><br />
<th style="padding: 12px; border: 1px solid #cbd5e1; color: #475569;">机制</th><br />
<th style="padding: 12px; border: 1px solid #cbd5e1; color: #1e40af;">临床意义</th><br />
</tr><br />
<tr><br />
<td style="padding: 10px; border: 1px solid #cbd5e1; font-weight: 600;">EGFR 突变肺癌</td><br />
<td style="padding: 10px; border: 1px solid #cbd5e1;">[[奥希替尼]] 抑制 ERK -> Bim 积累 -> 凋亡。</td><br />
<td style="padding: 10px; border: 1px solid #cbd5e1;">Bim 的诱导水平直接决定疗效。Bim 低表达提示耐药。</td><br />
</tr><br />
<tr><br />
<td style="padding: 10px; border: 1px solid #cbd5e1; font-weight: 600;">Bim 缺失多态性</td><br />
<td style="padding: 10px; border: 1px solid #cbd5e1;">BCL2L11 基因内含子缺失导致产生缺乏 BH3 域的无功能异构体。</td><br />
<td style="padding: 10px; border: 1px solid #cbd5e1; color: #b91c1c;">在东亚人群中常见（~12%），携带者对 TKI 治疗反应较差（PFS 缩短）。</td><br />
</tr><br />
<tr><br />
<td style="padding: 10px; border: 1px solid #cbd5e1; font-weight: 600;">自身免疫病</td><br />
<td style="padding: 10px; border: 1px solid #cbd5e1;">Bim 负责清除自身反应性 T/B 细胞。</td><br />
<td style="padding: 10px; border: 1px solid #cbd5e1;">Bim 缺陷小鼠发生系统性红斑狼疮（SLE）样疾病。</td><br />
</tr><br />
</table><br />
</div><br />
<br />
<div style="font-size: 0.92em; line-height: 1.6; color: #1e293b; margin-top: 50px; border-top: 2px solid #0f172a; padding: 15px 25px; background-color: #f8fafc; border-radius: 0 0 10px 10px;"><br />
<span style="color: #0f172a; font-weight: bold; font-size: 1.05em; display: inline-block; margin-bottom: 15px;">学术参考文献 [Academic Review]</span><br />
<br />
<p style="margin: 12px 0; border-bottom: 1px solid #e2e8f0; padding-bottom: 10px;"><br />
[1] <strong>O'Connor L, et al. (1998).</strong> <em>Bim: a novel member of the Bcl-2 family that promotes apoptosis.</em> <strong>[[EMBO Journal]]</strong>. <br><br />
<span style="color: #475569;">[点评]：历史性文献，首次克隆并描述了 Bim，确立了其作为最强效 BH3-only 蛋白的地位。</span><br />
</p><br />
<br />
<p style="margin: 12px 0; border-bottom: 1px solid #e2e8f0; padding-bottom: 10px;"><br />
[2] <strong>Puthalakath H, et al. (1999).</strong> <em>The proapoptotic activity of the Bcl-2 family member Bim is regulated by interaction with the dynein motor complex.</em> <strong>[[Molecular Cell]]</strong>. <br><br />
<span style="color: #475569;">[点评]：揭示了 BimEL/L 被微管骨架“囚禁”的独特调控机制，解释了细胞如何防止意外凋亡。</span><br />
</p><br />
<br />
<p style="margin: 12px 0; border-bottom: 1px solid #e2e8f0; padding-bottom: 10px;"><br />
[3] <strong>Cragg MS, et al. (2007).</strong> <em>Gefitinib-induced killing of NSCLC cell lines... requires Bim and can be blocked by Bcl-2.</em> <strong>[[PLoS Medicine]]</strong>. <br><br />
<span style="color: #475569;">[点评]：确立了 Bim 是 EGFR-TKI 治疗肺癌产生疗效的关键执行者，连接了靶向治疗与凋亡机制。</span><br />
</p><br />
</div><br />
<br />
<div style="margin: 40px 0; border: 1px solid #e2e8f0; border-radius: 8px; overflow: hidden; font-family: 'Helvetica Neue', Arial, sans-serif; font-size: 0.9em;"><br />
<div style="background-color: #eff6ff; color: #1e40af; padding: 8px 15px; font-weight: bold; text-align: center; border-bottom: 1px solid #dbeafe;"><br />
Bim · 知识图谱<br />
</div><br />
<table style="width: 100%; border-collapse: collapse; background-color: #ffffff;"><br />
<tr style="border-bottom: 1px solid #f1f5f9;"><br />
<td style="width: 85px; background-color: #f8fafc; color: #334155; font-weight: 600; padding: 10px 12px; text-align: right; vertical-align: middle;">上游调控</td><br />
<td style="padding: 10px 15px; color: #334155;">[[FOXO3a]] (转录) • [[ERK]] (降解) • [[JNK]] (激活)</td><br />
</tr><br />
<tr style="border-bottom: 1px solid #f1f5f9;"><br />
<td style="width: 85px; background-color: #f8fafc; color: #334155; font-weight: 600; padding: 10px 12px; text-align: right; vertical-align: middle;">异构体</td><br />
<td style="padding: 10px 15px; color: #334155;">[[BimEL]] (最丰富) • [[BimL]] • [[BimS]] (最毒)</td><br />
</tr><br />
<tr style="border-bottom: 1px solid #f1f5f9;"><br />
<td style="width: 85px; background-color: #f8fafc; color: #334155; font-weight: 600; padding: 10px 12px; text-align: right; vertical-align: middle;">生理功能</td><br />
<td style="padding: 10px 15px; color: #334155;">[[失巢凋亡]] • [[阴性选择]] (T细胞) • [[自身免疫]]</td><br />
</tr><br />
<tr><br />
<td style="width: 85px; background-color: #f8fafc; color: #334155; font-weight: 600; padding: 10px 12px; text-align: right; vertical-align: middle;">临床应用</td><br />
<td style="padding: 10px 15px; color: #334155;">[[EGFR-TKI]] 敏感性 • [[BH3模拟物]] (Venetoclax)</td><br />
</tr><br />
</table><br />
</div><br />
<br />
</div></div>
77921020